PIM
LAB icon

Partner Investment Management’s Standard BioTools LAB Stock Holding History

Partner Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$132K Buy
37,856
+2,504
+7% +$8.81K 0.95% 30
2019
Q3 		$164K Buy
35,352
+21,131
+149% +$166K 0.28% 57
2019
Q2 		$175K Sell
14,221
-403
-3% -$5.13K 0.19% 72
2019
Q1 		$194K Buy
+14,624
New +$154K 0.22% 73

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Partner Investment Management's LAB Position: Q4 2019 in Review

Partner Investment Management increased its Standard BioTools (LAB) stake by 7.1% in Q4 2019, buying an estimated $8.81K and bringing the position to 37,856 shares worth $132K. The position accounts for 0.95% of the portfolio, ranked #30.

Partner Investment Management first reported a position in LAB in Q1 2019 and has held it in 4 quarters since. The position peaked at $194K in Q1 2019. 99 funds tracked by Wall St. Rank hold LAB as of Q4 2019.

  • Partner Investment Management held 37,856 shares of Standard BioTools worth $132K as of Q4 2019.
  • Partner Investment Management bought 2,504 Standard BioTools shares in Q4 2019, an estimated $8.81K.
  • Standard BioTools made up 0.95% of Partner Investment Management's portfolio in Q4 2019, its #30 holding.
  • Partner Investment Management first reported a position in Standard BioTools in Q1 2019 and has held it in 4 quarters since.
  • Partner Investment Management's Standard BioTools position peaked at $194K in Q1 2019.
  • 99 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.